American Healthcare REIT heads into its Q1 2026 print today with a notable split: short sellers have been quietly adding exposure over the past week, even as options traders lean unusually bullish.
The short side has been building with purpose. Short interest climbed 10.7% over the past week to reach 8.3% of the free float — a meaningful position for a healthcare REIT. The surge follows a dramatic unwind in April: shorts had been cut nearly in half through mid-April as the stock rose, but positioning has crept back higher in each of the last six sessions. The ORTEX short score has moved in lockstep, rising from 49.7 a week ago to 55.9 as of Wednesday. Despite the build, the borrow market is relaxed — cost to borrow is just 0.5%, and share availability is ample, meaning the short rebuilding is not being squeezed by supply constraints.
Options positioning tells a sharply different story. The put/call ratio is running near its 52-week low at 0.089, well below the 20-day average of 0.110 and almost one standard deviation light on downside hedging. That's the least protective options market has been all year for AHR, suggesting call-side demand is driving flow into the print. The stock closed at $49.60, down 0.8% on the day and 2.3% on the week — a modest pullback, but still up 5.2% over the past month. Among healthcare REIT peers, gained 1.0% and added 0.4% on Thursday, while lagged — suggesting some stock-specific caution rather than sector-wide pressure.
The analyst community remains constructive. Targets were lifted across the board earlier in the year, with Truist Securities, Scotiabank, and Citigroup all raising price objectives in March. The consensus target of $57.92 implies roughly 16% upside from current levels. The bull thesis centres on a $600 million acquisition pipeline for 2026, projected 11.8% CAGR in senior housing and skilled nursing, and improving Medicare reimbursement supporting the Trilogy segment. Bears point to tenant default risk, concentration in skilled nursing facilities, and the sensitivity of REIT valuations to capital market conditions. The EV/EBITDA multiple of 22.2x has been broadly stable over the past month, while the P/E of 61x reflects the REIT's reliance on funds-from-operations rather than conventional earnings — though the dividend score ranks in the 77th percentile, signalling income quality is considered solid.
The Q1 print will test whether the company's organic growth trajectory and acquisition momentum justify a price that has already recovered sharply from the April tariff-driven sell-off — and whether short sellers who rebuilt positions this week have found the right entry.
See the live data behind this article on ORTEX.
Open AHR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
